WebPROLIEVE THERMODILATATION SYSTEM FDA Premarket Approval P030006 S007. FDA.report › PMA › MEDIFOCUS, INC › P030006 S007. This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more … Webprolieve thermodilitation system: MEDIFOCUS, INC: P030006 S020: 12/09/2008: prolieve thermodilitation system: MEDIFOCUS, INC: P030006 S021: 06/19/2009: prolieve ...

Post-Marketing Study Using PROLIEVE® for the Treatment of …

WebProlieve Thermodilatation Catheter Kit, a Transurethral Microwave Therapy (TUMT) System, for BPH (Benign Prostatic Hyperplasia) Thermotherapy, Material Numbers M0068808022 and M0068808170. Manufacturer Boston Scientific Corporation Manufacturer Boston Scientific Corporation Manufacturer Address WebDevice Description: Prolieve Thermodilatation System CLOSE. Device Characteristics. What MRI safety information does the labeling contain? Labeling does not contain MRI Safety … country ian

Treatment of benign prostatic hyperplasia using ... - Semantic …

WebProlieve ® is a minimally invasive day procedure that uses heat to treat Benign Prostate Hyperplasia (BPH), the non-cancerous enlargement of the prostate. Unlike traditional … WebThe FDA approved device Prolieve® is for the treatment of Benign Prostatic Hyperplasia (BPH). BPH is the enlargement of the male prostate gland which affects over 50 percent of men over the age of 50. Medifocus is currently deriving revenue from the sales of the Prolieve® device. WebThe Prolieve® Thermodilatation™ System offers potential relief to the millions of men who suffer from Benign Prostatic Hyperplasia (BPH), a condition that becomes common as … country iata codes